Ashlee Negrone summarises a systematic review and meta-analysis on omega-3 supplements for depression and anxiety in adults, and briefly introduces their Active Ingredients project on omega-3 for youth depression and anxiety.
[read the full story...]
Alice Potter explores a systematic review which finds that children and young people are often satisfied with the CBT (cognitive behavioural therapy) they receive for anxiety or depression.
[read the full story...]
Dona Matthews summarises a comprehensive global meta-analysis that presents our best current knowledge on the age of onset of various mental disorders. This review has major implications for our mental health promotion and prevention efforts.
[read the full story...]
Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.
[read the full story...]
In their debut blog, Martin Rimvall and Pia Jeppesen summarise a recent systematic review and meta-analysis exploring psychosis risk in children and adolescents with an ‘At Risk Mental State’.
[read the full story...]
Ian Hamilton appraises a systematic review and meta-analysis on the association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence.
[read the full story...]
Felicity Pearce, Bani Kahai and Derek Tracy summarise a recent meta-analysis examining safety planning-type interventions for suicide prevention.
[read the full story...]
Anjuli Kaul blogs about a new systematic review and meta-analysis of longitudinal cohort studies, which explores the relationship between PTSD and all-cause dementia.
[read the full story...]
Francesca Bentivegna summarises a recent review which suggests that schizophrenia, “personality disorders” and psychopathy may be linked to reading skills deficits in some people.
[read the full story...]
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]
